The popularity of GLP-1 weight loss drugs is bringing back a historic affliction once suffered by sailors on long journeys at sea. There are reports that those taking the drugs, which include medications like Ozempic and Wegovy, are being diagnosed with scurvy, an illness once common in the 17th and 18th centuries that is now considered rare in developed countries. Once the province of pirates, scurvy is caused by a deficiency in vitamin C. The condition once accounted for up to 50% of deaths of sailors at sea, until it was discovered that providing those on long voyages with citrus fruit would prevent them from becoming ill.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
